Security key
98943L107
Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)
CUSIP: 98943L107
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock,$0.001 par value per share
- Shares outstanding
- 72,096,078
- Total 13F shares
- 43,560,789
- Share change
- +2,849,494
- Total reported value
- $101,671,381
- Put/Call ratio
- 14%
- Price per share
- $2.34
- Number of holders
- 100
- Value change
- +$8,469,947
- Number of buys
- 51
- Number of sells
- 36
Report period
Q1 2026
Institutions
100
Top holders
10
ZNTL full security history
Previous quarter: Q4 2025
Zentalis Pharmaceuticals, Inc. SEC filings
Zentalis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98943L107
Recent filing periods:
Top shareholders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WALTERS GROUP |
13D/G
3/4/5
|
Walters William T · 10%+ Owner |
20%
|
13,509,973
|
$20,264,960 | $0 | 31 Dec 2025 | |
| Walters William T. |
13D/G
|
— |
9.9%
|
7,050,000
|
$10,081,500 | +$786,500 | 29 Jan 2025 | |
| 5AM Opportunities II (GP), LLC |
13D/G
|
Andrew J. Schwab |
6.4%
|
4,838,571
|
$7,257,856 | $0 | 18 Dec 2025 | |
| BARCLAYS PLC |
13D/G
13F
|
Company |
5.3%
|
3,841,449
|
$5,800,588 | $0 | 30 Sep 2025 | |
| Squadron Capital Management LLC |
13D/G
|
Squadron Master Fund LP |
5.1%
|
3,676,900
|
$9,376,095 | $0 | 24 Feb 2026 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
4.6%
|
3,271,240
|
$4,677,873 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
2.2%
|
1,613,323
|
$1,952,121 | $0 | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
1.3%
|
902,521
|
$1,272,555 | -$4,059,076 | 30 Sep 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
0.2%
from 13D/G
|
243,308
|
$328,466 | — | 31 Dec 2025 | |
| Matrix Capital Management Company, LP |
3/4/5
|
10%+ Owner |
9%
|
6,459,973
|
$8,591,764 | -$9,975,000 | 15 Dec 2025 | |
| Scott Dunseth Myers |
3/4/5
|
Director |
0.47%
|
338,795
|
$403,166 | — | 17 Jun 2025 | |
| David M. Johnson |
3/4/5
|
Director |
0.35%
|
250,421
|
$298,000 | — | 17 Jun 2025 | |
| Jan Skvarka |
3/4/5
|
Director |
0.29%
|
207,154
|
$246,513 | — | 17 Jun 2025 | |
| Luke Nathaniel Walker |
3/4/5
|
Director |
0.2%
|
144,284
|
$171,697 | — | 17 Jun 2025 | |
| Enoch Kariuki |
3/4/5
|
Director |
0.19%
|
137,365
|
$163,464 | — | 17 Jun 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
5.5%
|
3,947,913
|
$5,329,683 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4%
|
2,883,745
|
$3,893,056 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
4%
|
2,849,294
|
$3,839,000 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.7%
|
1,964,255
|
$2,651,744 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.3%
|
1,660,378
|
$2,241,510 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2.1%
|
1,483,500
|
$2,002,725 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
2%
|
1,471,414
|
$1,986,409 | — | 31 Dec 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
1.9%
|
1,400,906
|
$1,891,223 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.9%
|
1,367,254
|
$1,845,793 | — | 31 Dec 2025 | |
| Decheng Capital LLC |
13F
|
Company |
1.8%
|
1,323,327
|
$1,786,491 | — | 31 Dec 2025 | |
| Ishara Investments LP |
13F
|
Company |
1.8%
|
1,320,000
|
$1,782,000 | — | 31 Dec 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
1.6%
|
1,169,573
|
$1,579,000 | — | 31 Dec 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
1.3%
|
957,420
|
$1,292,517 | — | 31 Dec 2025 | |
| PFIZER INC |
13F
|
Company |
1.3%
|
953,834
|
$1,287,675 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
803,654
|
$1,084,932 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.1%
|
787,055
|
$1,062,524 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.94%
|
674,598
|
$910,707 | — | 31 Dec 2025 | |
| Almitas Capital LLC |
13F
|
Company |
0.85%
|
610,073
|
$823,599 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.82%
|
589,105
|
$795,720 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.8%
|
576,707
|
$778,554 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.74%
|
530,582
|
$716,286 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.66%
|
473,175
|
$638,786 | — | 31 Dec 2025 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
0.64%
|
463,700
|
$625,995 | — | 31 Dec 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
0.62%
|
448,861
|
$605,962 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.58%
|
419,367
|
$566,145 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.38%
|
271,790
|
$366,917 | — | 31 Dec 2025 | |
| Creative Planning |
13F
|
Company |
0.36%
|
260,000
|
$351,000 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.34%
|
247,788
|
$334,513 | — | 31 Dec 2025 | |
| Anfield Capital Management, LLC |
13F
|
Company |
0.34%
|
242,605
|
$327,517 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.26%
|
188,582
|
$254,586 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.26%
|
185,007
|
$249,759 | — | 31 Dec 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.23%
|
167,100
|
$225,585 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.19%
|
137,568
|
$185,717 | — | 31 Dec 2025 | |
| Quarry LP |
13F
|
Company |
0.18%
|
132,000
|
$178,200 | — | 31 Dec 2025 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.18%
|
130,407
|
$232,124 | — | 31 Dec 2025 |
Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q1 2026
As of 31 Mar 2026,
Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,560,789 shares.
The largest 10 holders included
5AM Venture Management, LLC, Squadron Capital Management LLC, TWO SIGMA INVESTMENTS, LP, ACADIAN ASSET MANAGEMENT LLC, VANGUARD CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, D. E. Shaw & Co., Inc., Opaleye Management Inc., and Decheng Capital LLC.
This page lists
100
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
85
Q1 2026 holders
100
Holder diff
15
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.